Showing results (581-590 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|January 30, 2004
Oral versus intramuscular cobalamin treatment in megaloblastic anemia: a single-center, prospective, randomized, open-label studyZahit Bolaman, Gurhan Kadikoylu, Vahit Yukselen, et al.
Clinical Therapeutics|September 1, 1992
Comparison of the efficacy and tolerability of Prinivil and Procardia XL in black and white hypertensive patientsM R Weir, P T Lavin
Clinical Therapeutics|December 25, 2003
Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthmaNancy K Ostrom
Clinical Therapeutics|December 25, 2003
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonistKelli L Davis, Jean M Nappi
Clinical Therapeutics|December 25, 2003
Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preferencePeter Ströberg, Aileen Murphy, Tim Costigan
Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.
Clinical Therapeutics|July 18, 2003
Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancerJohn F R Robertson, William Odling-Smee, Chris Holcombe, et al.
Clinical Therapeutics|July 18, 2003
Randomized, open-label, parallel-group, multicenter study of the efficacy and tolerability of IV gatifloxacin with the option for oral stepdown gatifloxacin versus IV ceftriaxone (with or without erythromycin or clarithromycin) with the option for oral stepdown clarithromycin for treatment of patients with mild to moderate community-acquired pneumonia requiring hospitalizationJoão Carlos Corrêa, Roberto Badaró, Chaiwat Bumroongkit, et al.
Clinical Therapeutics|July 18, 2003
A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998Jun Ma, Randall S Stafford, Iain M Cockburn, et al.
Clinical Therapeutics|July 18, 2003
A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a carFran Ridout, Ziba Shamsi, Robert Meadows, et al.
Pageof 676